Novo Nordisk

Study Start-Up Analyst

Novo Nordisk  •  Buenos Aires, AR (Hybrid)  •  1 day ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Department: Clinical Trial Operations, International Operations

Location: Vicente López, Buenos Aires. Hybrid working.

Your impact begins here

As Study Start Up Analyst, you will help clinical trials in Argentina get started on time and the right way. You will prepare and submit the documents that Health Authorities and Ethics Committees need to approve a trial. When your work is accurate and fast, sites can start sooner. That keeps research moving for people living with serious chronic diseases.

What you’ll bring

  • A university degree in Life Sciences, Pharmacy or a related field.
  • Experience in regulatory work for clinical trials at a CRO or pharmaceutical company, and hands-on experience with ICH GCP
  • Experience with trial systems such as CTMS and eTMF
  • Knowledge of regulatory submissions: local rules, dossier requirements and clinical trial applications
  • Advanced English.
  • A sharp eye for detail and the ability to organise and prioritise your work.
  • Strong communication skills.
  • A team player mindset.

What you’ll do

You will own start-up and submission activities for your assigned trials, from the first plan to green light – the final approval for a site to start.

  • Lead and coordinate the preparation, review and submission of Health Authority and Ethics Committee dossiers for your assigned trials, in line with ICH GCP, local regulations and Novo Nordisk processes
  • Co-develop the start-up plan with Trial Managers and the Trial Start-Up Manager, and plan and track regulatory milestones at country and site level
  • Adapt, translate and validate key documents – such as informed consent forms, patient materials, labels and clinical trial application documents – including updates requested by authorities
  • Drive green light activities: collect essential documents, perform quality control, file in eTMF and keep local trial registries and safety submissions up to date
  • Identify site-level and compliance risks early, act to prevent or mitigate them, and support inspection readiness, audits and inspections
  • Share local regulatory insights with trial teams and regional and global colleagues, and contribute to improving how start-up and submissions work

Who you’ll work with

You will join Clinical Trial Operations team and report to Adriana Demes, Trial Start-Up Manager. Every day, you will work with Trial Managers and local trial teams.

You will also build strong relationships with trial sites, Ethics Committees, Health Authorities and vendors. Good teamwork here keeps trials on track.

What you can expect here

You will own important work from the start, and your ideas will be heard. You will learn from experts in clinical, regulatory and quality, and build skills that help you grow. We move fast, support each other and never compromise on patient safety or quality.

Start now

Your impact begins today. Apply for the Study Start Up Analyst role by 10 October 2026.

Novo Nordisk is an equal opportunity employer. We welcome applications from all qualified candidates. Every application is considered without regard to gender, gender identity, sexual orientation, age, ethnicity, nationality, religion, disability, marital status or any other characteristic protected by law. If you need adjustments during the recruitment process, let us know.

Novo Nordisk

About Novo Nordisk

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.

Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.

This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.

Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:

https://www.novonordisk.com/contact-us/find-local-information.html

For other customer complaints, please contact us here:

https://www.novonordisk.com/contact-us.html

Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.

Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.

Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Industry
Chemicals & Materials
Company Size
10,000+ employees
Headquarters
Bagsværd, DK
Year Founded
1923
Social Media